Status:
COMPLETED
Novofine Autocover Safety Needle Versus BD Safety Glide
Lead Sponsor:
Novo Nordisk A/S
Conditions:
Diabetes
Healthcare Professionals
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
This trial is conducted in the United States of America (USA). The aim of this trial is to examine whether nurses prefer to use the NovoFine® Autocover Needle or the BD Safety Glide (TM) Syringe (only...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Hospital nurses with prior injection training without an infectious blood borne disease
Exclusion
Key Trial Info
Start Date :
July 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2006
Estimated Enrollment :
83 Patients enrolled
Trial Details
Trial ID
NCT00121355
Start Date
July 1 2005
End Date
June 1 2006
Last Update
October 18 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Novo Nordisk Investigational Site
Plainsboro, New Jersey, United States, 08536